Abstract |
In order to study the role of interleukin-6 (IL-6) in inflammatory disease we monitored plasma levels of IL-6 and acute phase proteins such as C-reactive protein (CRP) and renin substrate (RS) in patients with reactive arthritis (ReA), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE). Venous plasma samples were collected: (1) during the acute phase or exacerbation of the disease, and (2) several months latter during convalescence. Increased mean [95% confidence intervals (CI)] levels of plasma IL-6 were observed in patients with ReA both in the acute phase and later, 229 (177 to 280) ng/l and 197 (134 to 260) ng/l respectively (P less than 0.001 as compared to controls). The corresponding plasma IL-6 levels in RA patients were 283 (223 to 340) ng/l and 183 (151 to 226) ng/l, respectively (P less than 0.001 as compared to controls). Plasma IL-6 levels in SLE patients were not increased. Plasma RS levels were increased in all patient groups, but no significant correlation to IL-6 or CRP levels was observed, whereas plasma IL-6 and CRP levels showed a positive correlation in ReA and RA patients.
|
Authors | K P Metsärinne, D C Nordström, Y T Konttinen, A M Teppo, F Y Fyhrquist |
Journal | Rheumatology international
(Rheumatol Int)
Vol. 12
Issue 3
Pg. 93-6
( 1992)
ISSN: 0172-8172 [Print] Germany |
PMID | 1384103
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Acute-Phase Proteins
- Interleukin-6
- PHB2 protein, human
- Prohibitins
- Angiotensinogen
- C-Reactive Protein
|
Topics |
- Acute-Phase Proteins
(analysis)
- Adult
- Aged
- Angiotensinogen
(blood)
- Arthritis, Reactive
(blood, epidemiology)
- Arthritis, Rheumatoid
(blood, epidemiology)
- C-Reactive Protein
(analysis)
- Female
- Follow-Up Studies
- Humans
- Interleukin-6
(blood)
- Lupus Erythematosus, Systemic
(blood, epidemiology)
- Male
- Middle Aged
- Prohibitins
- Prospective Studies
|